Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × valrubicin × Clear all

NCT00003129 2023-06-22

Chemotherapy in Treating Patients With Early-Stage Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms

NCT00003759 2013-01-31

AD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder Cancer

Phase 2 Completed

Urinary Bladder Neoplasms